MedTrace Logo

Frequent Ketamine Use and Gastrointestinal, Liver and Biliary Sequelae

NCT02165488 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2020-03-25

No results posted yet for this study

Summary

30% of ketamine users complain of abdominal discomfort. Long-term ketamine use is associated with hepatotoxicity and pathologic changes to the biliary tract. Yet the prevalence of gastrointestinal and hepatobiliary pathologies in ketamine users has not been well-described. The investigators plan to recruit a large number of ketamine users based on referrals from different Psychiatry clusters in Hong Kong and to investigate the underlying cause of abdominal discomfort, describe the prevalence of different gastrointestinal and hepatobiliary pathologies and describe their long-term outcome.

Conditions

  • Gastritis
  • Peptic Ulcer Disease
  • Cholangiopathy
  • Liver Fibrosis

Sponsors & Collaborators

  • The University of Hong Kong

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2019-05-31
Completion
2019-12-31

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02165488 on ClinicalTrials.gov